GeneFerm Biotechnology Co., Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was TWD 143.91 million compared to TWD 113.87 million a year ago. Net income was TWD 20.5 million compared to TWD 11.34 million a year ago. Basic earnings per share from continuing operations was TWD 0.5 compared to TWD 0.31 a year ago. Diluted earnings per share from continuing operations was TWD 0.46 compared to TWD 0.3 a year ago.